Immunocompetence

Inclusion Body Hepatitis (IBH)

Inclusion Body Hepatitis is an acute viral disease of the liver, primarily affecting young broiler chickens.

MEVAC Inclusion Body Hepatitis (IBH)
01
Disease Overview

Overview

Inclusion Body Hepatitis is an acute viral disease of the liver, primarily affecting young broiler chickens. It is caused by various serotypes of Fowl Adenovirus (FAdV) and is characterized by sudden mortality spikes.

02
Disease Behavior

Pathogenicity

The virus targets hepatocytes, causing severe liver necrosis and the formation of intranuclear inclusion bodies. IBH is frequently seen as a secondary complication in flocks already immunosuppressed by other viruses like IBD or Chicken Infectious Anemia (CIA).

03
Disease Presentation

Clinical Signs

Clinical signs are often non-specific until mortality begins:

General

Sudden onset of lethargy, drooping wings, and decreased appetite.

Specific

Yellowish diarrhea and pale/jaundiced combs or wattles.

Necropsy

The liver appears swollen, friable (crumbly), and pale with focal necrotic areas.

04
Disease Spread

Transmission & Viral Shedding

Vertical Transmission

The virus can be passed from infected breeders to their offspring through the egg (egg-borne).

Horizontal Transmission

Spreads through the fecal-oral route or via contaminated nasal/ocular secretions.

Latency

Adenoviruses can remain latent in a flock and reactivate during periods of stress.

05
Identification

Diagnosis and Timeline

Incubation

Variable, but clinical outbreaks usually occur in broilers between 3 and 7 weeks of age.

Diagnosis

Based on characteristic liver lesions during necropsy and confirmed via histopathology (identifying basophilic inclusion bodies in liver cells) or virus isolation from liver tissue.

06
Farm Protection

Prevention & Control

Breeder Vaccination

Ensuring breeders are vaccinated or naturally immune is the primary way to prevent vertical transmission to chicks.

Immune Support

Controlling immunosuppressive diseases (IBD, CIA) is crucial to reducing the clinical impact of FAdV.

Biosecurity

Standard hygiene protocols to limit horizontal spread between pens or farms.

Symptoms to Monitor

Clinical Signs

Yellowish diarrhea
Weight loss
Lethargy
Decreased appetite
Pale comb/wattles
Listlessness
Depression
Poor condition